Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

8.7%

2 terminated out of 23 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

17%

4 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed with results

Key Signals

83% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (11)
P 2 (1)
P 3 (1)
P 4 (3)

Trial Status

Completed10
Unknown4
Recruiting3
Terminated2
Active Not Recruiting1
Not Yet Recruiting1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT07565558Not ApplicableCompleted

Evaluation of the Effectiveness of the Socket Preservation Technique Using Allogeneic and Xenogeneic Materials

NCT07561489Enrolling By Invitation

A Prospective, Single-center, Observational Clinical Outcomes Study for Vertebral Compression Fractures Treated With the OsteoPearl Biological Allograft Implants

NCT02882828Phase 4CompletedPrimary

PK Assessment of Tacrolimus Exposure Before and After a Switch From Twice Daily Immediate-release (Prograf®) to Once-daily Prolonged Release Tacrolimus (Envarsus®)

NCT07210541Completed

Comparative Analysis of Stented Biological Prosthesis Versus Aortic Allograft in Patients With Degenerative Aortic Valve Disease

NCT06676696Phase 4Recruiting

Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure

NCT05459181Not ApplicableNot Yet Recruiting

HeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)

NCT06644092Not ApplicableActive Not Recruiting

Investigation of the Effectiveness of Physiotherapy and Rehabilitation After Osteochondral Allograft Transplantation Operation

NCT06591000RecruitingPrimary

Clinical Efficacy and Long-term Outcomes of ALLOgraft Versus Stented Biological Prosthesis for Primary TRIcuspid Valve Disease (ALLOTRI)

NCT05096351RecruitingPrimary

Immunological Reaction of the Recipient After Cold-stored Saphenous Venous Allograft (Bioprotec)

NCT05258929TerminatedPrimary

RElapse After Allograft: Link Between LoCus of Control and QualiTy of Life

NCT03829072Not ApplicableCompletedPrimary

Cooking Education and Adapted Physical Activity in Allografted Patients

NCT06219473Phase 4UnknownPrimary

Efficacy of Fascia Lata Allograft and Platelet Rich Fibrin on the Periodontal Phenotype Around Dental Implant

NCT05536492Not ApplicableCompleted

Sticky Bone Compared to A-PRF(Platlet Rich Fibrin) Effect on Alveolar Ridge Preservation

NCT04021316Not ApplicableTerminated

Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration

NCT05423496Not ApplicableWithdrawn

KidneyCare Immuno-optimization in Renal Allografts (KIRA)

NCT05510011Unknown

Allograft and Tantalum Cone Reconstruction in TKA Revision

NCT05164835Not ApplicableUnknownPrimary

Study of Drug Acceptance and Its Persistence Over Time in Patients Receiving a Haematopoietic Stem Cell Allograft

NCT00384540Not ApplicableCompleted

Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide Coupling

NCT03402776Phase 3Unknown

Impact of a Fourth Hexavalent Vaccine After Hematopoietic Stem Cell Transplantation

NCT03009708Not ApplicableCompletedPrimary

Feasibility Study of Platelet Activation and Inflammatory Response of Platelets in Hematopoietic Stem Cell Allograft Patients Post-transplant: Spontaneously and After Stimulation by an CMV Antigen

Scroll to load more

Research Network

Activity Timeline